by NDASA | Jul 17, 2024 | Drug Legislation, Feature, Marijuana & CBD
The Honorable Merrick B. Garland Attorney GeneralU.S. Department of Justice The Honorable Anne Milgram, Administrator Drug Enforcement Administration8701 Morrissette DriveSpringfield, Virginia 22152 Submitted via Electronic DocketJuly 17 , 2024 Re: Part 2 of 2 of the...
by Guest Contributer | Jul 15, 2024 | Advocacy, Drug Legislation, Feature, Marijuana & CBD, Workplace Safety
By Bill Current, Founder of the Current Consulting Group It’s been said that elections have consequences, including unintended consequences that can be harmful, nonetheless. The Drug Enforcement Administration (DEA), at President Biden’s direction, intends to...
by Guest Contributer | May 3, 2024 | Drug Legislation, Feature, Industry News, Uncategorized
Courtesy of American Substance Abuse Professionals AP News reports that the US Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug. Reclassifying marijuana as a less dangerous drug creates medical and...
by NDASA | Jan 23, 2024 | Marijuana & CBD, Substance Use
By Buzzkill Labs Although state lawmakers approved Assembly Bill 2188 more than a year ago, there is still a lack of clarity about what it means for employers in California. Even some drug testing service providers are under the impression that AB 2188 spells the end...
by NDASA | Apr 23, 2021 | For Drug Testing Industry Professionals, For Employers and Workplace Safety & Wellness Professionals, Marijuana & CBD, Resources
The Institute for Behavior and Health, Inc., is a nonprofit organization based in Rockville, Md., that develops strategies to reduce drug use. President Robert L. DuPont, M.D., was the lead author on an extensive 2015 report titled, “Workplace Drug Testing in the Era...
by NDASA | Apr 23, 2021 | For Drug Testing Industry Professionals, Marijuana & CBD, Resources
“We want to make it perfectly clear that the state initiatives will have no bearing on the Department of Transportation’s regulated drug testing program. The Department of Transportation’s Drug and Alcohol Testing Regulation – 49 CFR Part 40 – does not authorize the...
by NDASA | Apr 23, 2021 | For Employers and Workplace Safety & Wellness Professionals, Marijuana & CBD, Resources, Uncategorized
“Don’t Drop Marijuana” explains why marijuana and THC, the active ingredient of the cannabis plant, should not be dropped from drug-testing programs and panels. Please click here to review the video on Vimeo.com. This video is produced by Drug Free Business, a...
by NDASA | Apr 23, 2021 | For Employers and Workplace Safety & Wellness Professionals, Resources
As NDASA Members, we are often asked these common questions that can cause confusion and frustration for employers when it comes to employee marijuana use, the workplace drug & alcohol policy and workplace safety. Below is a simple Q&A you may find helpful...
by NDASA | Apr 23, 2021 | For Employers and Workplace Safety & Wellness Professionals, Marijuana & CBD, Resources
This is a quick-hit handout designed to promote understanding about CBD, an ingredient of the cannabis plant. To download this guide in a .pdf file format, please click here. CBD There is currently NO over-sight by the U.S. Food & Drug Administration of the CBD...
by NDASA | Apr 23, 2021 | For Employers and Workplace Safety & Wellness Professionals, Marijuana & CBD, Resources
Marijuana is an impairing substance. The user experiences reduced motor coordination, short-term memory loss and altered reaction time, all of which has destructive effects in the workplace. High doses of THC, the active ingredient in the cannabis plant, can cause...
